Market Newsdesk

LOS ANGELES, Aug. 13, 2026 (GLOBE NEWSWIRE) — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Planet Fitness, Inc. (“Planet Fitness” or “the Company”) (NYSE: PLNT) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of PLNT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: November 6, 2025 to May 6, 2026

DEADLINE: September 14, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Planet Fitness failed to effectively roll out a national price increase on its Black Card offering. The Company overstated its growth outlook. The Company exaggerated its ability to drive new member joins with its existing market campaign. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Planet Fitness, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.        

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

Schall, Brown & Schwartz LLP

RICHMOND, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced the opening of Toll Brothers at Revera, a new luxury home community in Richmond, Texas. Located approx. 30 miles southwest of Houston, the community offers an impressive selection of modern home designs and access to resort-style amenities, providing home shoppers with an unparalleled living experience. The Sales Center and Lavaca Transitional professionally designed model home is now open at 1615 Seaside Horizon Lane in Richmond.

Toll Brothers at Revera features expertly crafted single-family homes on spacious 50- and 60-foot-wide home sites. Home shoppers can choose from a wide array of 3 to 5 bedroom floor plans ranging from 2,230 to 3,901 square feet of living space and options for personalization. Homes are priced from the mid-$400,000s.

“We are thrilled to show off our newest model home and bring Toll Brothers’ design and craftsmanship to Richmond with the opening of our Toll Brothers at Revera community,” said Brian Murray, Division President of Toll Brothers in Houston. “This community offers the perfect blend of luxury living, modern conveniences, and resort-style amenities in a prime location.”

Toll Brothers customers will experience one-stop shopping at the Toll Brothers Design Studio. The state-of-the-art Design Studio allows home shoppers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants.

Residents of Toll Brothers at Revera will enjoy access to a variety of master-planned amenities, including a resort-style pool, clubhouse, pickleball courts, playgrounds, and scenic lakes. The community is also located within the highly regarded Lamar Consolidated Independent School District and is just minutes from local dining, shopping, and entertainment options.

For more information about Toll Brothers at Revera and other Toll Brothers communities in Texas, call 833-289-8655 or visit TollBrothers.com/TX.

About Toll Brothers

Toll Brothers, Inc., a Fortune 500 Company, is the nation’s leading builder of luxury homes. The Company was founded in 1967 and became a public company in 1986 with common stock listed on the New York Stock Exchange under the symbol “TOL.” Toll Brothers builds new homes and communities in over 60 markets across the United States, serving first-time, move-up, active-adult, and second-home buyers. The Company also operates its own architectural, engineering, mortgage, title, land development, smart home technology, landscape, and building components manufacturing businesses.

Toll Brothers was named the #1 Most Admired Home Builder in Fortune magazine’s 2026 list of the World’s Most Admired Companies®, the ninth year the Company has achieved this honor. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com.

From Fortune, ©2026 Fortune Media IP Limited. All rights reserved. Used under license.

Contact: Andrea Meck | Toll Brothers, Senior Director, Public Relations & Social Media | 215-938-8169 | [email protected]

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/42627b65-b54a-4e97-b674-c7d30fc40200

https://www.globenewswire.com/NewsRoom/AttachmentNg/cf75c695-be63-4312-9314-7c57f4de452a

Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG)

LOS ANGELES, Aug. 13, 2026 (GLOBE NEWSWIRE) — Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intuit Inc. (“Intuit” or “the Company”) (NASDAQ: INTU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of INTU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: August 22, 2025 to May 20, 2026

DEADLINE: September 8, 2026

If you are a shareholder who suffered a loss, click here to participate.

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. Intuit overstated the strength and sustainability of its business as well as its competitive advantages. The Company was losing its market share in its Turbo Tax in particular due in part to pricing pressure. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Intuit, investors suffered damages.

We also encourage you to contact Brian Schall or David Schwartz of Schall, Brown & Schwartz LLP, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected].

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Join the case to recover your losses

WHY SBS? Schall, Brown & Schwartz LLP represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. Bringing together the extensive experience and diverse skillsets of founding partners Brian Schall, Andrew Brown, and David Schwartz, SBS is dedicated to aggressively advocating for every investor.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Schall, Brown & Schwartz LLP
Brian Schall, Esq.,
Andrew Brown, Esq.,
David Schwartz, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]

SOURCE:

Schall, Brown & Schwartz LLP

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) — Shareholders of Exelixis, Inc. (NASDAQ: EXEL) watched the stock decline in after-hours trading following the Company’s second quarter results, in which adjusted earnings per share of $0.91 exceeded estimates while revenue of approximately $628.7 million came in below consensus. Investors who lost money on EXEL are encouraged to submit their information here. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

Two numbers, one quarter. The adjusted profitability figure beat. The top-line sales figure missed. Coverage of the results from marketscreener.com stated that the primary catalyst for the decline “was a revenue miss relative to Wall Street expectations, despite an adjusted EPS beat.”

Levi & Korsinsky is investigating potential securities law violations concerning Exelixis, including whether the Company adequately conveyed to investors the state of its underlying sales performance.

Shareholders who purchased EXEL and suffered a loss may request a free case evaluation. You may also contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

Levi & Korsinsky, LLP — Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.

Frequently Asked Questions About the EXEL Investigation

Q: Who is eligible to participate in the EXEL investigation? A: Investors who purchased EXEL stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: Which statements are being investigated? A: The investigation concerns whether Exelixis made materially false or misleading statements regarding its commercial performance and revenue trajectory. Second quarter revenue of approximately $628.7 million came in below consensus expectations, and the stock declined.

Q: Who is conducting the EXEL investigation? A: Levi & Korsinsky, LLP is investigating potential securities fraud claims on behalf of investors who purchased EXEL securities. The firm is nationally recognized and has recovered hundreds of millions of dollars for aggrieved investors.

Q: What do EXEL investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my EXEL shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought EXEL and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis — no retainer, no out-of-pocket costs.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) — Three months after telling investors it expected full-year revenue of $810 million to $830 million, LegalZoom.com, Inc. (NASDAQ: LZ) reduced that outlook to approximately $795 million to $805 million on August 5, and shares fell. If you lost money on LegalZoom stock, you are encouraged to submit your LZ losses for review. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

The timeline: On May 6, 2026, LegalZoom’s earnings release stated that “[r]evenue is expected to be in the range of $810 million to $830 million” and that the outlook “reflects the continued scaling of our higher-value growth initiatives and ongoing momentum from our partner channel through the remainder of the year.” On August 5, 2026, the Company guided third-quarter revenue to $194 million — below analyst estimates — and lowered the full-year range. Management attributed the change to declining Google search traffic as AI-generated answers replace clicks, and to paid search becoming more expensive and less efficient.

Separately, in its DEF 14A submitted April 22, 2026, the Company stated: “AI is making our services more relevant, not less.” Following the August 5 outlook reduction, JPMorgan and William Blair both downgraded LZ, citing reduced growth visibility and search-channel uncertainty.

Shareholders who purchased LegalZoom stock and suffered losses may request a free case evaluation here or call (212) 363-7500.

WHY LEVI & KORSINSKY — Ranked in ISS Securities Class Action Services’ Top 50 Report for seven consecutive years, Levi & Korsinsky, LLP is a nationally recognized leader in shareholder rights litigation. With a team of over 70 professionals, the firm has recovered hundreds of millions of dollars for investors.

Frequently Asked Questions About the LZ Investigation

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether LegalZoom.com, Inc. made materially false or misleading statements regarding its full-year revenue outlook and the durability of its customer-acquisition channels. On August 5, 2026, the Company reduced full-year revenue guidance to approximately $795-$805 million from $810-$830 million and guided third-quarter revenue below estimates, and the stock declined.

Q: When did LegalZoom allegedly mislead investors? A: The investigation concerns statements made before the August 5, 2026 outlook reduction that allegedly caused investors to purchase securities at inflated prices.

Q: Who is eligible to participate in the LZ investigation? A: Investors who purchased LZ stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: What do LZ investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my LZ shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought LZ and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis — no upfront fees, no retainer, and no out-of-pocket costs.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) — ATS Corporation (NYSE: ATS) shareholders took losses after the Company reported Q1 fiscal 2027 revenue of C$693.7 million — down 5.8% year over year and roughly C$6.3 million below the low end of the C$700 million to C$740 million range management had guided just weeks earlier. If you suffered a loss on your ATS investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

The same quarter produced a net loss of C$0.3 million, compared with net income of C$24.3 million a year earlier. Revenue also came in below the C$724.0 million FactSet consensus estimate. Alongside the results, management announced a new 18-month fixed-cost transformation program.

On the August 6, 2026 earnings call, Interim CFO, VP, and Corporate Controller, Anne Cybulski indicated the results “reflect[ed] the lower opening order backlog and the planned reduction in transportation-related activity.” Notably ATS’ reported backlog of C$1.889 billion had faltered 8.7% year-over-year and more than 3.5% sequentially. Levi & Korsinsky is investigating whether ATS may not have adequately disclosed the scale of these risks to investors.

Shareholders who lost money on ATS are encouraged to have their losses reviewed at no cost or call (212) 363-7500.

ABOUT LEVI & KORSINSKY, LLP — Over the past 20 years, Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders. The firm has extensive expertise in complex securities litigation and a team of over 70 employees. For seven consecutive years, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report.

Frequently Asked Questions About the ATS Investigation

Q: What is the ATS investigation about? A: A securities investigation is pending concerning ATS Corporation regarding whether the Company adequately disclosed operating and internal-control risks. Shares declined after ATS reported Q1 fiscal 2027 revenue of C$693.7 million, below its guided range, and a swing to a net loss.

Q: Who is eligible to participate in the ATS investigation? A: Investors who purchased ATS stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: How much did ATS stock drop? A: Shares fell by $7.42 (26.55%) to close at approximately $20.53 per share on August 6, 2026, following the reveal of ATS’ first quarter results. Investors who purchased shares and suffered losses may be eligible to seek recovery.

Q: What do ATS investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my ATS shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought ATS and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost. Securities investigations and any resulting actions are generally handled on a contingency basis — no retainer and no out-of-pocket costs.

Q: What if I live outside the United States? A: U.S. securities fraud investigations generally cover purchases on U.S. exchanges regardless of the investor’s country of residence.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

Ed Korsinsky, Esq.

33 Whitehall Street, 27th Floor

New York, NY 10004

[email protected]

Tel: (212) 363-7500

Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) — Universal Technical Institute (NYSE: UTI) shareholders watched the stock drop after the Company paired 7.2% revenue growth with a fiscal 2026 baseline adjusted EBITDA outlook of above $135 million, down from more than $155 million. Investors who lost money on UTI shares are encouraged to submit their loss information now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

The two numbers landed together. Revenue for the quarter: $218.9 million, up 7.2% year over year. Baseline adjusted EBITDA guidance for the full year: cut by approximately $20 million, or roughly 13% off the prior figure. Enrollment metrics improved in the same period.

Management attributed approximately 70% of the EBITDA reduction to weaker-than-expected fourth-quarter starts in the high-school auto and diesel channel. The remainder was attributed to a faster mix shift toward shorter-duration, lower-margin programs. Levi & Korsinsky is investigating potential securities law violations on behalf of UTI investors.

Shareholders who purchased UTI stock and suffered a loss are encouraged to click here to learn more about the investigation, or contact Joseph E. Levi, Esq. at [email protected] or (212) 363-7500.

Levi & Korsinsky, LLP — Top 50 securities litigation firm (ISS, seven consecutive years). Over 70 professionals. Hundreds of millions recovered.

Frequently Asked Questions About the UTI Investigation

Q: Who is eligible to participate in the UTI investigation? A: Investors who purchased UTI stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: How much did UTI stock drop? A: Shares declined sharply following the fiscal Q3 2026 earnings release, from a closing price of $42.37 on August 5, 2026, share price declined to close at only $27.87, a fall of $14.50 per share, or nearly 35%. Investors who purchased UTI shares and suffered losses may be eligible to seek recovery.

Q: Who is conducting the UTI investigation? A: Levi & Korsinsky, LLP is investigating potential securities fraud claims on behalf of investors who purchased UTI securities. The firm is nationally recognized, ranked in the ISS Top 50 for seven consecutive years, and has recovered hundreds of millions of dollars for aggrieved investors.

Q: What do UTI investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500. No immediate action is required to remain eligible to participate in the investigation.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my UTI shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought UTI and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost to participate. Securities investigations and any resulting actions are generally handled on a contingency basis. No upfront fees, no retainer, and no out-of-pocket costs.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.

NEW YORK, Aug. 13, 2026 (GLOBE NEWSWIRE) — A revenue and earnings beat did not stop Emergent BioSolutions (NYSE: EBS) shares from falling sharply after the Company’s second-quarter release, which disclosed a $191.3 million non-cash NARCAN impairment tied to naloxone competition and pricing pressure. Investors who lost money on EBS are encouraged to submit their information now. You may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

The quarter itself came in ahead of the Company’s prior revenue guidance at approximately $234 million, with adjusted EBITDA of roughly $97 million, up sequentially. Within the same results, Emergent recorded the $191.3 million impairment against NARCAN, citing increased competition and pricing pressure in the naloxone category.

Five months earlier, in its February 26, 2026 earnings presentation, the Company had stated: “Maintained market leadership; pricing stabilized.” Levi & Korsinsky is investigating potential securities law violations on behalf of Emergent BioSolutions shareholders.

Shareholders who purchased EBS stock and suffered a loss are encouraged to have their losses reviewed today or call (212) 363-7500.

ABOUT THE FIRM — For over two decades, Levi & Korsinsky has represented shareholders in securities class actions. Ranked in ISS Top 50 for seven consecutive years.

Frequently Asked Questions About the EBS Investigation

Q: How much did EBS stock drop? A: Shares fell sharply after the Company disclosed a $191.3 million non-cash NARCAN impairment alongside its second-quarter results. Investors who purchased EBS securities and suffered losses may be eligible to seek recovery.

Q: Which statements are being investigated as potentially misleading? A: The investigation concerns whether Emergent BioSolutions made materially false or misleading statements regarding NARCAN pricing and competitive conditions, including the February 26, 2026 statement that naloxone pricing had “stabilized,” before the Company disclosed the $191.3 million NARCAN impairment.

Q: Who is eligible to participate in the EBS investigation? A: Investors who purchased EBS stock or securities and suffered financial losses may be eligible. Eligibility is based on purchase date and documented losses — not on whether you still hold the shares.

Q: What do EBS investors need to do right now? A: Gather brokerage records including purchase dates, share quantities, and prices paid. Contact Levi & Korsinsky for a free, no-obligation evaluation at [email protected] or (212) 363-7500.

Q: What documents do I need to participate? A: Brokerage statements or trade confirmations showing purchase dates, share quantities, prices paid, and any subsequent sale dates and prices.

Q: What if I already sold my EBS shares — can I still recover losses? A: Yes. Eligibility is based on when you purchased, not whether you still hold the shares. Investors who bought EBS and sold at a loss may still participate in the investigation.

Q: What does it cost me to participate? A: There is no upfront cost. Securities investigations and any resulting actions are generally handled on a contingency basis — no retainer and no out-of-pocket costs.

Q: Do I need to go to court or give testimony? A: No. Participating in the investigation does not require court appearances or depositions.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171

Attorney Advertising. Prior results do not guarantee similar outcomes.